Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 3296294, 10 pages
https://doi.org/10.1155/2017/3296294
Review Article

Sestrin2 as a Novel Biomarker and Therapeutic Target for Various Diseases

1College of Pharmacy, Qatar University, P.O. Box 2713, Doha, Qatar
2Department of Pharmacology and Toxicology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
3Department of Biological and Environmental Sciences, College of Arts and Sciences, Qatar University, P.O. Box 2713, Doha, Qatar
4Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
5School of Medicine, University of Texas Health Sciences Center at San Antonio, San Antonio, TX, USA

Correspondence should be addressed to Shankar Munusamy; aq.ude.uq@ymasunum.raknahs

Received 4 March 2017; Accepted 3 May 2017; Published 11 June 2017

Academic Editor: Alexander N. Orekhov

Copyright © 2017 Mazhar Pasha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Mazhar Pasha, Ali H. Eid, Assaad A. Eid, Yves Gorin, and Shankar Munusamy, “Sestrin2 as a Novel Biomarker and Therapeutic Target for Various Diseases,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 3296294, 10 pages, 2017. https://doi.org/10.1155/2017/3296294.